SE0100296D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0100296D0
SE0100296D0 SE0100296A SE0100296A SE0100296D0 SE 0100296 D0 SE0100296 D0 SE 0100296D0 SE 0100296 A SE0100296 A SE 0100296A SE 0100296 A SE0100296 A SE 0100296A SE 0100296 D0 SE0100296 D0 SE 0100296D0
Authority
SE
Sweden
Prior art keywords
new compounds
relates
present
compounds
methylbenzylamino
Prior art date
Application number
SE0100296A
Other languages
Swedish (sv)
Inventor
Mikael Dahlstroem
Franz Langkilde
Karin Loevqvist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100296A priority Critical patent/SE0100296D0/en
Publication of SE0100296D0 publication Critical patent/SE0100296D0/en
Priority to ARP020100273A priority patent/AR032519A1/en
Priority to PCT/SE2002/000163 priority patent/WO2002060441A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Abstract

The present invention relates to novel crystalline forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt. Further, the present invention also relates to use of said compounds for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them and processes for obtaining them.
SE0100296A 2001-02-01 2001-02-01 New compounds SE0100296D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0100296A SE0100296D0 (en) 2001-02-01 2001-02-01 New compounds
ARP020100273A AR032519A1 (en) 2001-02-01 2002-01-25 COMPOUNDS
PCT/SE2002/000163 WO2002060441A1 (en) 2001-02-01 2002-01-30 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100296A SE0100296D0 (en) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
SE0100296D0 true SE0100296D0 (en) 2001-02-01

Family

ID=20282798

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100296A SE0100296D0 (en) 2001-02-01 2001-02-01 New compounds

Country Status (3)

Country Link
AR (1) AR032519A1 (en)
SE (1) SE0100296D0 (en)
WO (1) WO2002060441A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2506027A1 (en) 2002-11-19 2004-06-03 Altana Pharma Ag 8-substituted imidazopyridines
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (en) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
WO2007043939A1 (en) * 2005-10-07 2007-04-19 Astrazeneca Ab Novel crystalline form of 3,5-dibromo-n- [(2s)-2-(-4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl] -n-methylbenzamide, modification a

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2002060441A1 (en) 2002-08-08
AR032519A1 (en) 2003-11-12

Similar Documents

Publication Publication Date Title
PT1625126E (en) Imidazo and thiazolopyridines as jak3 kinase inhibitors
WO2003095455A3 (en) Substituted pyrazolopyrimidines
ATE301653T1 (en) PYRAZOLOPYRIDINES
WO2006107771A3 (en) PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
ATE332301T1 (en) ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
ES2340502T3 (en) COMPOUNDS OF 1,4,8-TRIAZAESPIRO (4,5) DECAN-2-ONA SUBSTITUTED FOR THE TREATMENT OF OBESITY.
CY1109366T1 (en) Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One
NO20070837L (en) Pyrido-pyrido pyrimidine derivatives, their preparation and therapeutic application for the treatment of cancer.
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2003080608A3 (en) Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
SI1869038T1 (en) SUBSTITUTED 5,6,7,8-TETRAHYDRO-IMIDAZO?á1,2-A?åPYRIDIN-2-YLAMINE COMPOUNDS AND THEIR USE FOR PRODUCING DRUGS
MY134123A (en) Citrate salt of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
PL366858A1 (en) Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
ATE242242T1 (en) DERIVATIVES OF IMIDAZO(1,2-A)PYRIDINE FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
SE0100296D0 (en) New compounds
ATE274515T1 (en) PYRAZOLOPYRIDINE DERIVATIVES
SE0100297D0 (en) New compounds
SE0100295D0 (en) New compounds
SE0303451D0 (en) New compounds
HUP0103912A3 (en) Substituted alkylpyridazinone derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions with anxiolytic activity
ATE365040T1 (en) CHIRAL DINAPSOLINE
HK1056362A1 (en) Triazolo Ä4,5-dÜ pyrimidine derivatives as anti-thrombotic agents